Search Tag: cardiovascular disease
Impact-of-cardiac-radiation-on-risk-of-coronary-artery-disease
2020 27 Jan
Over the years, there has been significant progress in the treatment of children with cancer. This has resulted in an increase in the number of cancer survivors living into adulthood. However, significant impact has been observed on the long-term health of these individuals, with many of them experiencing chronic health issues related to previous treatment....Read more
Cardiovascular-screening-programmes-at-top-cardiology-hospitals
2020 27 Jan
There is very little evidence that screening tests reduce mortality in asymptomatic individuals. However, clinicians have a strong belief that diagnostic tests can help find disease in its earliest stages. That is why many top-ranking hospitals offer executive screening programmes that are primarily targeted to wealthy individuals who can afford to...Read more
Top-heart-disease-stroke-research-advances-in-2019
2020 15 Jan
Cardiovascular disease continues to be the leading cause of death worldwide. Over the years, scientific research and technological advancements in heart disease and stroke science have had a positive impact on the diagnosis and treatment of cardiovascular disease. Here is a quick overview of the biggest scientific victories achieved in 2019, as...Read more
Top-cardiology-stories-of-2019
2019 27 Dec
As we move into 2020, here's a quick recap of our most clicked stories in Cardiology in 2019: ORION-10 Trial: Inclisiran Effective at Reducing LDL Findings from the ORION-10 trial presented at the AHA Scientific Session in 2019 showed that twice-yearly injections of inclisiran were effective at reducing LDL cholesterol. ENCOURAGE...Read more
Aspirin-no-longer-effective-as-primary-prevention-for-cvd
2019 16 Dec
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. Nearly half of adults 70 years...Read more
Esc-statistics-2019-middle-income-european-countries-most-affected-by-cvd
2019 16 Dec
Middle-income countries shoulder the bulk of morbidity and mortality from cardiovascular disease (CVD) in Europe, according to a major report published today in European Heart Journal. The document details the burden of CVD in the 57 ESC member countries, the infrastructure and human resources available for treatment, and the vast differences...Read more
Aspirin-in-primary-prevention
2019 01 Dec
Aspirin (acetylsalicylic acid) has the unique ability to to irreversibly acetylate serine in the active site of cyclo-oxygenase (COX), permanently blocking its action in prostaglandin synthesis. This results in analgesic, antipyretic, and anti-inflammatory effects. In the platelet, it has a more durable and sustained effect. However, while aspirin...Read more
Sleep-disturbances-socioeconomic-inequalities-and-cardiovascular-disease
2019 01 Dec
Insufficient sleep is one reason why disadvantaged groups have more heart disease. That’s the finding of a study published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC). People with lower socioeconomic status sleep less for a variety of reasons: they may do several jobs, work in shifts, live in noisy environments,...Read more
Encourage-trial-simple-nudges-improve-statin-prescription-adherence
2019 23 Nov
Statins are an effective medication for treating patients with heart disease. They cut the risk of a second major adverse cardiac event by almost 50$. But only about 6% of patients take statins as prescribed. One way to solve that? Nudge them. Literally. In a new study presented to heart specialists from around the world, researchers at the Intermountain...Read more
Running-lowers-risk-of-death
2019 14 Nov
There has been extensive literature on the benefits of exercise, including running. Not only does running improve physical endurance, it has been shown to lower body weight, enable better control of blood pressure and blood glucose, improve mental health and lower the risk of adverse cardiac events. However, current literature on how much to run, at...Read more
The-future-of-cardiovascular-medicine-technology-gender-bias-and-treatment-strategies
2019 13 Nov
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions...Read more
Cash-cow-infographic
2019 13 Nov
An overview of healthcare industry revenue, growth and expenditures. Read more
Statins-in-children-with-familial-hypercholesterolaemia
2019 21 Oct
Familial hypercholesterolaemia is typically characterised by severely elevated low-density lipoprotein (LDL) cholesterol levels and premature cardiovascular disease. While the short-term efficacy of statin therapy in children is well established, there is still a lack of longer follow-up studies to evaluate specific changes in the risk of cardiovascular...Read more
The-sex-and-gender-influence-on-hypertension
2019 02 Oct
Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not...Read more
All-in-one-pill-reduces-blood-pressure
2019 23 Sep
A combination pill containing three medications used to tackle high blood pressure and one used for high cholesterol was found to reduce cardiovascular disease (CVD) risk by 25%. The study, published in the New England Journal of Medicine (NEJM), assessed the effectiveness of atorvastatin, amlodipine, losartan and hydrochlorothiazide in polypill...Read more
Esccongress-cardiovascular-medicine-will-never-be-the-same
2019 29 Aug
ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. The ESC Congress...Read more
The-future-of-cardiovascular-disease-treatment-and-management
2019 26 Aug
Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more
Cardiology-and-mhealth-rethink-about-monitoring
2019 26 Aug
Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation. Where Are We Now? Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)...Read more
Sex-gender-impacts-in-cardiovascular-disease-a-typical-presentation-of-cardiovascular-disease
2019 26 Aug
Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine. Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education...Read more
Cardiovascular-disease-prevention-2019-quo-vadis
2019 26 Aug
Summary: Cardiovascular disease prevention strategies in 2019 remain a major healthcare issue, requiring an individualised approach for diagnostic and therapeutic decision making. Introduction Since investigators from the Framingham Heart Study first confirmed the existence and importance of cardiovascular disease (CVD) risk factors in...Read more
Nuclear-cardiology-molecular-insights-into-the-heart
2019 26 Aug
Summary: Nuclear cardiology is a promising field located between research, imaging, and patient care. Through close interdisciplinary cooperation, a variety of cardiovascular diseases (eg coronary artery, inflammatory and infiltrative cardiac diseases) can not only be investigated, but also efficiently treated in daily clinical routine. What...Read more
Hypertension-prevention-is-better-than-cure
2019 26 Aug
How can we get the most common, costly, and modifiable cardiovascular risk factor under control? Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor...Read more
Ideal-cardiovascular-health-metrics-and-major-cardiovascular-events
2019 01 Aug
The prevalence of Type 2 diabetes has become a public health issue, as the International Diabetes Federation recorded a total of 425 million adults between the ages of 20 and 79 that had diabetes in 2017. The main cause of disability and mortality in this cohort is due to issues involving cardiovascular health. The American Heart Association has now...Read more
Aspirin-efficacy-all-in-the-genes
2019 25 Jul
The benefits of low-dosages of aspirin (75-100mg daily) for the secondary prevention of cardiovascular diseases (CVDs) exceed the risk of bleeding. However, most are still unclear whether aspirin has the same effects on primary prevention. The recent results from three trials ASPREE, ASCEND and ARRIVE each tested the effects of 100mg of aspirin...Read more
Smoking-and-risk-of-cardiovascular-disease
2019 08 Jul
The most in-depth study in the world on smoking risks to cardiovascular health reveals 17 Australian smokers die each day from heart attacks, strokes and other cardiovascular conditions. The Australian National University (ANU) conducted a study, in partnership with the Heart Foundation and the Sax Institute, with 190,000 Australian smokers and...Read more
Pet-ct-detects-cardiovascular-disease-risk-in-sleep-apnoea-patients
2019 26 Jun
Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting draws a strong link between severe obstructive sleep apnea (OSA) and impaired coronary flow reserve, which is an early sign of the heart disease atherosclerosis. Using 13N-ammonia positron emission tomography/computed tomography (PET/CT), researchers...Read more
Dietetic-consultation-for-lowering-lipid-levels
2019 26 Jun
Change in dietary behaviour is considered to be a first-line approach to the prevention and management of cardiovascular disease risk. Dietitians can help change behaviour and modify risk factors by educating and counselling patients. This is particularly true for patients who are at an increased risk for cardiovascular disease. Dietary changes...Read more
7th-international-conference-on-preht-ht-cms-2020
2020 15 Oct
NEW DATES DUE TO COVID-19 : 15 - 18 OCTOBER 2020 Find PreHT on Social Media Read more
Ultra-processed-foods-and-all-cause-mortality
2019 05 Jun
One of the major drivers of chronic disease is nutrition. Clinical evidence clearly proves that dietary habits can have a significant influence on our cardiometabolic health and could lead to Type 2 diabetes, stroke, and heart disease. In addition, a poor quality diet also increases the overall economic burden on healthcare. In fact, studies have...Read more